Publications Team I / équipe 1

Publications Team I / équipe 12018-08-16T11:27:33+00:00

Publications :

Année 2018

(Liste des Publications par ordre alphabétique du premier auteur)

Les divers membres de l’équipe sont en gras


Ahmed E, Sansac C, Assou S, Gras D, Petit A, Vachier I, Chanez P, De Vos J, Bourdin A. (2018). “Lung development, regeneration and plasticity: From disease physiopathology to drug design using induced pluripotent stem cells.Pharmacol Ther. 2018 Mar;183:58-77. (IF= 10,38).

Battault S, Meziat C, Nascimento A, Braud L, Gayrard S, Legros C, De Nardi F, Drai J, Cazorla O, Thireau J, Meyer G, Reboul C. (2018). “Vascular endothelial function masks increased sympathetic vasopressor activity in rats with metabolic syndrome. “ Am J Physiol Heart Circ Physiol. 2018 Mar 1;314(3):H497-H507. (IF=3,57).

Ben Bouallègue F, Vauchot F, Bourdon A, Benkiran M, Boissin C, Charriot J, Bourdin A, Mariano-Goulart D. (2018). “RV function improvement following nitric oxide inhalation demonstrated by gated blood pool SPECT in a patient with primary pulmonary hypertension.J Nucl Cardiol. 2018 Jan 10. Sous presse. (IF=3,85).

Bourdin A, Suehs CM, Marin G, Vachier I, Matzner-Lober E, Chanez P, Molinari N; COBRA consortium  (2018).  “Asthma, COPD and overlap in a national cohort: ACO on a gradient.J Allergy Clin Immunol. 2018 Apr;141(4):1516-1518. (IF=13,26).

Bulsei J, Leroy S, Perotin JM, Mal H, Marquette CH, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Salaün M, Marceau A, Dukic S, Barbe C, Bonnaire M, Deslee G, Durand-Zaleski I; REVOLENS study group. (2018). “Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study).Respir Res. 2018 May 9;19(1):84. (IF=3,75).

Champéroux P, Fesler P, Judé S, Richard S, Le Guennec JY, Thireau J. (2018). “High Frequency Autonomic Modulation: a new model for analysis of autonomic cardiac control.Br J Pharmacol. 2018 Aug;175(15):3131-3143. (IF=6,81).

Choquet C, Nguyen THM, Sicard P, Buttigieg E, Tran TT, Kober F, Varlet I, Sturny R, Costa MW, Harvey RP, Nguyen C, Rihet P, Richard S, Bernard M, Kelly RG, Lalevée N, Miquerol L. (2018). “Deletion of Nkx2-5 in trabecular myocardium reveals the developmental origins of pathological heterogeneity associated with ventricular non-compaction cardiomyopathy.PLoS Genet. 2018 Jul 6;14(7):e1007502. PLoS Genet. 2018 Aug 15;14(8):e1007610.(IF=5,54).

Curinier C, Solecki K, Dupuy AM, Breuker C, Lotierzo M, Zerkowski L, Kalmanovich E, Akodad M, Adda J, Battistella P, Castet-Nicolas A, Kuster N, Marques S, Soltani S, Chettouh M, Verchere A, Belloc C, Roubille C, Fesler P, Mercier G, Cristol JP, Audurier Y, Roubille F. (2018). “Evaluation of the sST2-guided optimization of medical treatments of patients admitted for heart failure, to prevent readmission: Study protocol for a randomized controlled trial.Contemp Clin Trials. 2018 Jan 30;66:45-50. (IF= 2,66).

Daïen CI, Tubery A, Cailar GD, Mura T, Roubille F, Morel J, Bousquet J, Fesler P, Combe B. (2018). “Application of the 2015/2016 EULAR recommendations for cardiovascular risk in daily practice: data from an observational study.Ann Rheum Dis. 2018 Apr;77(4):625-626 (IF=12,35).

Daïen CI, Tubery A, Beurai-Weber M, Cailar GD, Picot MC, Roubille F, Cohen JD, Morel J, Bousquet J, Fesler P, Combe B. (2018). “Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases.Joint Bone Spine. 2018 Apr 11. Sous presse. (IF=3,30).

Eliet J, Gaudard P, Zeroual N, Rouvière P, Albat B, Mourad M, Colson PH. (2018). “Effect of Impella During Veno-Arterial Extracorporeal Membrane Oxygenation on Pulmonary Artery Flow as Assessed by End-Tidal Carbon Dioxide.ASAIO J. 2018 Jul/Aug;64(4):502-507  (IF=1,84).

Galano JM, Roy J, Durand T, Lee JC, Le Guennec JY, Oger C, Demion M. (2018). Biological activities of non-enzymatic oxygenated metabolites of polyunsaturated fatty acids (NEO-PUFAs) derived from EPA and DHA: New anti-arrhythmic compounds? Mol Aspects Med. 2018 Mar 20. Sous presse. (IF=7,34).

Gaudard P, Barbanti C, Rozec B, Mauriat P, M’rini M, Cambonie G, Liet JM, Girard C, Leger PL, Assaf Z, Damas P, Loron G, Lecourt L, Amour J, Pouard P. (2018). New Modalities for the Administration of Inhaled Nitric Oxide in Intensive Care Units After Cardiac Surgery or for Neonatal Indications: A Prospective Observational Study. Anesth Analg. 2018 Apr;126(4):1234-1240 (IF=3,46).

Gerges C, Gerges M, Fesler P, Maria Pistritto A, Konowitz NP, Jakowitwsch J, Celermajer DS, Lang IM. (2018). “In-depth hemodynamic phenotyping of pulmonary hypertension due to left heart disease.Eur Respir J. 2018 May 24;51(5).(IF=12,24).

Granier M, Laugaudin G, Massin F, Cade S, Winum PF, Freitag C, Pasquie JL.  (2018). “Occurrence of Incomplete Endothelialization Causing Residual Permeability After Left Atrial Appendage Closure.J Invasive Cardiol. 2018 Jul;30(7):245-250 (IF=1,54).

Haïssaguerre M, Hocini M, Cheniti G, Duchateau J, Sacher F, Puyo S, Cochet H, Takigawa M, Denis A, Martin R, Derval N, Bordachar P, Ritter P, Ploux S, Pambrun T, Klotz N, Massoullié G, Pillois X, Dallet C, Schott JJ, Scouarnec S, Ackerman MJ, Tester D, Piot O, Pasquié JL, Leclerc C, Hermida JS, Gandjbakhch E, Maury P, Labrousse L, Coronel R, Jais P, Benoist D, Vigmond E, Potse M, Walton R, Nademanee K, Bernus O, Dubois R. (2018) “Localized Structural Alterations Underlying a Subset of Unexplained Sudden Cardiac Death.Circ Arrhythm Electrophysiol. 2018 Jul;11(7):e006120.  (IF=4,71).

Halimi L, Marin G, Molinari N, Gamez AS, Boissin C, Suehs CM, Vachier I, Bourdin A. (2018). “Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension.J Psychosom Res. 2018 Feb;105:45-51. (IF=2,95). 

Jaffuel D, Molinari N, Berdague P, Pathak A, Galinier M, Dupuis M, Ricci JE, Mallet JP, Bourdin A, Roubille F. (2018). « Impact of sacubitril-valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO-SAS study design. ESC Heart Fail. 2018 Jun;5(3):222-230.

Lambert K, Hokayem M, Thomas C, Fabre O, Cassan C, Bourret A, Bernex F, Lees J, Demion M, Seyer P, Hugon G, Mercier J, Avignon A, Bisbal C. (2018). “No Additive Effects of Polyphenol Supplementation and Exercise Training on White Adiposity Determinants of High-Fat Diet-Induced Obese Insulin-Resistant Rats. “Oxid Med Cell Longev. 2018 Apr sous presse; (IF=4,94).

Léopold V, Gayat E, Pirracchio R, Spinar J, Parenica J, Tarvasmäki T, Lassus J, Harjola VP, Champion S, Zannad F, Valente S, Urban P, Chua HR, Bellomo R, Popovic B, Ouweneel DM, Henriques JPS, Simonis G, Lévy B, Kimmoun A, Gaudard P, Basir MB, Markota A, Adler C, Reuter H, Mebazaa A, Chouihed T. (2018). “Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients.Intensive Care Med. 2018 Jun;44(6):847-856. (IF=15,01).

Montani D, Henry J, O’Connell C, Jaïs X, Cottin V, Launay D, Habib G, Bourdin A, Jevnikar M, Savale L, Rottat L, Simonneau G, Sitbon O, Humbert M, Allanore Y. (2018). “Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry.Respiration. 2018;95(4):244-250.IF=2,59).

Ogier C, Colombo PE, Bousquet C, Canterel-Thouennon L, Sicard P, Garambois V, Thomas G, Gaborit N, Jarlier M, Pirot N, Pugnière M, Vie N, Gongora C, Martineau P, Robert B, Pèlegrin A, Chardès T, Larbouret C. (2018). Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer. Cancer Lett. 2018 Jun 20;432:227-236. (IF=6,49).

Rénier W, Bourdin A, Rubbo PA, Peries M, Dedieu L, Bendriss S, Kremer L, Canaan S, Terru D, Godreuil S, Nagot N, Van de Perre P, Tuaillon E. (2018). “B cells response directed against Cut4 and CFP21 lipolytic enzymes in active and latent tuberculosis infections. “ PLoS One. 2018 Apr 30;13(4):e0196470.  (IF=2,77).

Romano-Bertrand S, Evrevin M, Dupont C, Frapier JM, Sinquet JC, Bousquet E, Albat B, Jumas-Bilak E (2018). “Persistent Contamination of Heater-Cooler Units for Extracorporal Circulation Cured by Chlorhexidine-Alcohol in Water Tanks.J Hosp Infect. 2018 Jul;99(3):290-294. IF = 3,35).

Rouhana S, Farah C, Roy J, Finan A, Rodrigues de Araujo G, Bideaux P, Scheuermann V, Saliba Y, Reboul C, Cazorla O, Aimond F, Richard S, Thireau J, Fares N. (2018). “Early calcium handling imbalance in pressure overload-induced heart failure with nearly normal left ventricular ejection fraction “ BBA Molecular Basis of Disease 2018 sous presse. (IF=5,11).

Teiger E, Thambo JB, Defaye P, Hermida JS, Abbey S, Klug D, Juliard JM, Pasquie JL, Rioufol G, Lepillier A, Elbaz M, Horvilleur J, Brenot P, Pierre B, Le Corvoisier P; French National Left Atrial Appendage Closure Registry (FLAAC) Investigators. (2018). “Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events. » Circ Cardiovasc Interv. 2018 Mar;11(3):e005841.(IF=6,50)

Zeroual N, Samarani G, Gallais J, Culas G, Saour M, Mourad M, Gaudard P, Colson PH. (2018). “ScvO2 changes after red-blood-cell transfusion for anaemia in cardiothoracic and vascular ICU patients: an observational study.Vox Sang. 2018 Feb;113(2):136-142 (IF=2,11).


Année 2017

Bardin PG, Price D, Chanez P, Humbert M, Bourdin A. (2017). “Managing asthma in the era of biological therapies.Lancet Respir Med. 2017 May;5(5):376-378. (IF=21,47).

Bergougnoux A, Petit A, Knabe L, Bribes E, Chiron R, De Sario A, Claustres M, Molinari N, Vachier I, Taulan-Cadars M, Bourdin A. (2017). “The HDAC inhibitor SAHA does not rescue CFTR membrane expression in Cystic Fibrosis.“. The International Journal of Biochemistry & Cell Biology 2017 Jul;88:124-132.. (IF=3,25).

Bommart S, Marin G, Molinari N, Knabe L, Petit A, Chanez P, Gamez AS, Devautour C, Vachier I, Bourdin A. (2017). “CCSP Serum Level is A Surrogate Marker of Small Airway Involvment in Asthma. “. J Allergy Clin Immunol. 2017 Aug;140(2):581-584. (IF=13,26).

Bonnet B, Jourdan F, du Cailar G, Fesler P. (2017). “Non invasive evaluation of left ventricular elastance according to pressure-volume curves modeling in arterial hypertension.Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H237-H243. (IF=3,57) .

Boucly A, Weatherald J, Savale L, Jaïs X, Cottin V, Prevot G, Picard F, de Groote P, Jevnikar M, Bergot E, Chaouat A, Chabanne C, Bourdin A, Parent F, Montani D, Simonneau G, Humbert M, Sitbon O. (2017). “Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.Eur Respir J. 2017 Aug 3;50(2). (IF=12,24).

Bourdin A, Molinari N. (2017). “[What are the socio-economic consequences of acute COPD exacerbations?] “ “ Rev Mal Respir. 2017 Apr;34(4):338-342 (IF=0,58).

Bourdin A, Molinari N, Vachier I, Pahus L, Suehs C, Chanez P. (2017). “Mortality: a neglected outcome in OCS-treated severe asthma. Eur Respir J. 2017 Nov 30;50(5). (IF= 12,24).

Branquinho RT, Roy J, Farah C, Garcia GM, Aimond F, Le Guennec JY, Saude-Guimarães DA, Grabe-Guimaraes A, Mosqueira VC, de Lana M, Richard S. (2017). “ Biodegradable Polymeric Nanocapsules Prevent Cardiotoxicity of Anti-Trypanosomal Lychnopholide. “ Sci Rep. 2017 Mar 28;7:44998. (IF=4,12).

Bussiere R, Lacampagne A, Reiken S, Liu X, Scheuerman V, Zalk R, Martin C, Checler F, MarksAR , and Chami M. (2017) “Amyloid β production is regulated by β2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor.Journal of Biological Chemistry Jun 16;292(24):10153-10168. (IF= 4,01).

Cabon Y, Molinari N, Marin G, Vachier I, Gamez AS, Chanez P and Bourdin A. (2017). “Comparison of anti-interleukin-5 therapies in patients with severe asthma: Global and indirect meta-analyses of randomized placebo-controlled trialsClin Exp Allergy. 2017 Jan;47(1):129-138.. (IF=5,16).

Cadelis G, Ducrot R, Bourdin A, Rastogi N. (2017). “Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.PLoS Negl Trop Dis. 2017 Aug 7;11(8):e0005841.  (IF=4,37).

Colomb S, Bareil C, Baccino E, Berthet JP, Knabe L, Vachier I, Bourdin A.(2017). “LIFE BEYOND LIFE – An Easy Way to Derive Lung Fibroblasts from Cadavers. J Forensic Sci. 2017 Sep;62(5):1339-1344 (IF=1,18).

Demion M, Oger C , Vigor C,  Thireau J, Le Guennec JY, Durand T, Galano JM, Chung-Yung Lee J. (2017).”Two sides of the same coin: NEO‐PUFAs in Rett syndrome and post‐infarction cardiac arrhythmias.” European Journal of Lipid Science and Technology. 2017 119 (6). 1600320 (1 of 7) (IF=2,20).

Deslée G, Leroy S, Perotin JM, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Salaün M, Marceau A, Dury S, Benzaquen J, Bonnaire M, Dukic S, Barbe C, Marquette CH; , on behalf of the REVOLENS Study Group13; REVOLENS Study Group. (2017). “Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study.Eur Respir J. 2017 Dec 21;50(6). (IF=12,24).

Faure EM, Khantalin I, Peyron PA, Canaud L, Marty-Ané C, Alric P. (2017). “Experimental Assessment of Physician Modified Proximal Scalloped Stent Graft to Extend Proximal Landing Zone in the Aortic Arch. “  Eur J Vasc Endovasc Surg. 2017 Aug;54(2):150-156. (IF=3,88).

Gueffier M, Zintz J, Lambert K, Finan A, Aimond F, Chakouri N, Hédon C, Granier M, Launay P, Thireau J, Richard S, Demion M. (2017). “ The TRPM4 channel is functionally important for the beneficial cardiac remodeling induced by endurance training. “  J Muscle Res Cell Motil. 2017 Feb;38(1):3-16. (IF=2,10).

Gras D, Martinez-Anton A, Bourdin A, Garulli C, de Senneville L, Vachier I, Vitte J, Chanez P.(2017). Human bronchial epithelium orchestrates dendritic cell activation in severe asthma.  Eur Respir J. 2017 Mar 8;49(3).(IF=12,24). 

Gras D, Petit A, Charriot J, Knabe L, Alagha K, Gamez AS, Garulli C, Bourdin A, Chanez P, Molinari N, Vachier I. (2017).  “ Epithelial ciliated beating cells essential for ex vivo ALI culture growth. “   BMC Pulm Med. 2017 May 3;17(1):80. (IF=2,72).

Hautefort A, Chesné J, Preussner J, Pullamsetti SS, Tost J, Looso M, Antigny F, Girerd B, Riou M, Eddahibi S, Deleuze JF, Seeger W, Fadel E, Simonneau G, Montani D, Humbert M and Perros F. (2017). “Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension. “Oncotarget 2017 May 19;8(32):52995-53016. (IF=5,17).

Jaffuel D, Mallet JP, Dauvilliers Y, Bourdin A. (2017). “Is the Muscle the Only Potential Target of Desipramine in Obstructive Sleep Apnea Syndrome?Am J Respir Crit Care Med. 2017 Jun 15;195(12):1677-1678.. (IF=15,24).

Jouneau S, Dres M, Guerder A, Bele N, Bellocq A, Bernady A, Berne G, Bourdin A, Brinchault G, Burgel PR, Carlier N, Chabot F, Chavaillon JM, Cittee J, Claessens YE, Delclaux B, Deslée G, Ferré A, Gacouin A, Girault C, Ghasarossian C, Gouilly P, Gut-Gobert C, Gonzalez-Bermejo J, Jebrak G, Le Guillou F, Léveiller G, Lorenzo A, Mal H, Molinari N, Morel H, Morel V, Noel F, Pégliasco H, Perotin JM, Piquet J, Pontier S, Rabbat A, Revest M, Reychler G, Stelianides S, Surpas P, Tattevin P, Roche N. (2017). “Management of acute exacerbations of chronic obstructive pulmonary disease (COPD). Guidelines from the Société de pneumologie de langue française (summary).Rev Mal Respir. 2017 Apr;34(4):282-322. (IF=0,58).

Khoueiry Z, Providencia R, Combes S, Combes N, Pasquie JL, Albenque JP, Boveda S. (2016). “Cryoablation of paroxysmal atrial fibrillation displayed the same results as radiofrequency despite anatomical variants of pulmonary veins.Europace. Oct 1;19(10):1754-1755 (IF= 5,23).

Le Guennec JY, Thireau J, Ouillé A, Roussel J, Roy J, Richard S, Richard S, Martel E, Champéroux P. (2017). “Corrigendum: Inter-individual variability and modeling of electrical activity: a possible new approach to explore cardiac safety?Sci Rep. 2017 Feb 16;7:42828. (IF=4,12)

Leroy S, Benzaquen J, Mazzetta A, Marchand-Adam S, Padovani B, Israel-Biet D, Pison C, Chanez P, Cadranel J, Mazières J, Jounieaux V, Cohen C, Hofman V, Ilie M, Hofman P, Marquette CH; AIR Project Study Group collaboration A. Bourdin .(2017). “Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France.BMJ Open. 2017 Dec 26;7(12):e018884. (IF=2,41).

Mercier O, Ataam JA,. Langer NB, r Dorfmüller P, Lamrani L, Lecerf  F, Decante B, Dartevelle P, Eddahibi S, Fadel E. (2017). “Abnormal pulmonary endothelial cells may underlie the enigmatic pathogenesis of chronic thromboembolic pulmonary hypertension..“.The Journal of Heart and Lung Transplantation. 2017 Mar;36(3):305-314. (IF=7,95).

Morra S, Bughin F, Solecki K, Aboubadra M, Lattuca B, Gouzi F, Macia JC, Cung TT, Cade S, Cransac F, Davy JM, Dauvilliers Y, Corrado D, Roubille F. (2017). “Prevalence of obstructive sleep apnoea in acute coronary syndrome: Routine screening in intensive coronary care units.Ann Cardiol Angeiol (Paris). 2017 Sep;66(4):223-229. (IF=0,27).

Nair P, Wenzel S, Rabe KF, Bourdin A, Lugogo NL, Kuna P, Barker P, Sproule S, Ponnarambil S, Goldman M; ZONDA Trial Investigators.. (2017). “Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.N Engl J Med. 2017 Jun 22;376(25):2448-2458 (IF=79,26).

Reboul C, Boissière J, André L, Meyer G, Bideaux P, Fouret G, Feillet-Coudray C, Obert P, Lacampagne A, Thireau J, Cazorla O, Richard S. (2017). Carbon monoxide pollution aggravates ischemic heart failure through oxidative stress pathway. Sci Rep. 2017 Jan 3;7:39715 (IF=4,12).

Rotty MC, Mallet JP, Borel JC, Suehs CM, Bourdin A, Molinari N, Jaffuel D. (2017). “The feasibility of a mandibular movement test as a screening tool for polysomnography candidates.Eur Respir J. 2017 Nov 30;50(5). (IF= 12,24).

Roy J, Le Guennec JY. (2016). “Cardioprotective effects of omega 3 fatty acids: origin of the variability.J Muscle Res Cell Motil. 2017 Feb;38(1):25-30 (IF=2,10).

Roy J, Fauconnier J, Oger C, Farah C, Angebault-Prouteau C, Thireau J, Bideaux P, Scheuermann V, Bultel-Poncé V, Demion M, Galano JM, Durand T, Lee JC, Le Guennec JY. (2017). “Non-enzymatic oxidized metabolite of DHA, 4(RS)-4-F4t-neuroprostane protects the heart against reperfusion injury.Free Radic Biol Med. 2017 Jan;102:229-239. (IF=6,02).

Roy J, Galano JM, Durand T, Le Guennec JY, Lee JC.(2017). “Physiological role of reactive oxygen species as promoters of natural defenses.FASEB J. 2017 2017 Sep;31(9):3729-3745 (IF=5,59). 

Sankhe S, Manousakidi S, Antigny F, Ataam JA, Bentebbal S, Ruchon Y, Lecerf F, Sabourin J, Price L, Fadel E, Dorfmüller P, Eddahibi S, Humbert M, Perros F, Capuano V. (2017). “T-type Ca2+ channels elicit pro-proliferative and anti-apoptotic responses through impaired PP2A/Akt1 signaling in PASMCs from patients with pulmonary arterial hypertension. T-type Ca2+ channels elicit pro-proliferative and anti-apoptotic responses through impaired PP2A/Akt1 signaling in PASMCs from patients with pulmonary arterial hypertension. BBA – Molecular Cell Research 2017 Oct;1864(10):1631-1641.(IF=4,65). 

Souza ACM, Mosqueira VCF, Silveira APA, Antunes LR, Richard S, Guimarães HN, Grabe-Guimarães A. (2017). “Reduced cardiotoxicity and increased oral efficacy of artemether polymeric nanocapsules in Plasmodium berghei-infected mice.Parasitology. 2017 Dec 10:1-9. (IF= 2,51).

Thireau J, Farah C, Molinari N, Bouilloux F, Torreilles L, Winkelmann J, Scholz S, Richard S, Dauvilliers Y, Marmigère F. (2017). “MEIS1 variant as a determinant of autonomic imbalance in Restless Legs Syndrome.Sci Rep. 2017 Apr 20;7:46620. (IF=4,12).

Yang Z, Kirton H, Al-Owais M, Thireau J, Richard S, Steele D, Peers C.  (2017). “Epac2-Rap1 signaling regulates reactive oxygen species production and susceptibility to cardiac arrhythmias. » Antioxid Redox Signal. 2017 Jul 20;27(3):117-132. (IF=6,53).

Année 2016

Berthet JP, Ambard D, Le Floc’h S, Canaud L, Alric P, Marty-Ané CH. (2016).”Reply. Ann Thorac Surg. 101(1):410-1. (IF=3,78).

Berthet JP, Solovei L, Bommart S, Ambard D, Canaud L, Alric P, Marty-Ané CH.(2016) “Reply.Ann Thorac Surg. ;101(2):833-4. (IF=3,78).

Bouilloux F*, Thireau J*, Ventéo S, Farah C, Karam S, Dauvilliers Y, Valmier J, Copeland NG, Jenkins NA, Richard S, Marmigère F. (2016).”Loss of the transcription factor Meis1 prevents sympathetic neurons target-field innervation and increases susceptibility to sudden cardiac death. .” Elife. 2016 Feb 8;5. pii: e11627. (IF= 7,72).

Bousquet J, Bourret R, Camuzat T, Augé P, Bringer J, Noguès M, Jonquet O, de la Coussaye JE, Ankri J, Cesari M, Guérin O, Vellas B, Blain H, Arnavielhe S, Avignon A, Combe B, Canovas G, Daien C, Dray G, Dupeyron A, Jeandel C, Laffont I, Laune D, Marion C, Pastor E, Pélissier JY, Galan B, Reynes J, Reuzeau JC, Bedbrook A, Granier S, Adnet PA, Amouyal M, Alomène B, Bernard PL, Berr C, Caimmi D, Claret PG, Costa DJ, Cristol JP, Fesler P, Hève D, Millot-Keurinck J, Morquin D, Ninot G, Picot MC, Raffort N, Roubille F, Sultan A, Touchon J, Attalin V, Azevedo C, Badin M, Bakhti K, Bardy B, Battesti MP, Bobia X, Boegner C, Boichot S, Bonnin HY, Bouly S, Boubakri C, Bourrain JL, Bourrel G, Bouix V, Bruguière V, Cade S, Camu W, Carre V, Cavalli G, Cayla G, Chiron R, Coignard P, Coroian F, Costa P, Cottalorda J, Coulet B, Coupet AL, Courrouy-Michel MC, Courtet P, Cros V, Cuisinier F, Danko M, Dauenhauer P, Dauzat M, David M, Davy JM, Delignières D, Demoly P, Desplan J, Dujols P, Dupeyron G, Engberink O, Enjalbert M, Fattal C, Fernandes J, Fouletier M, Fraisse P, Gabrion P, Gellerat-Rogier M, Gelis A, Genis C, Giraudeau N, Goucham AY, Gouzi F, Gressard F, Gris JC, Guillot B, Guiraud D, Handweiler V, Hayot M, Hérisson C, Heroum C, Hoa D, Jacquemin S, Jaber S, Jakovenko D, Jorgensen C, Kouyoudjian P, Lamoureux R, Landreau L, Lapierre M, Larrey D, Laurent C, Léglise MS, Lemaitre JM, Le Quellec A, Leclercq F, Lehmann S, Lognos B, Lussert CM, Makinson A, Mandrick K, Mares P, Martin-Gousset P, Matheron A, Mathieu G, Meissonnier M, Mercier G, Messner P, Meunier C, Mondain M, Morales R, Morel J, Mottet D, Nérin P, Nicolas P, Nouvel F, Paccard D, Pandraud G, Pasdelou MP, Pasquié JL, Patte K, Perrey S, Pers YM, Portejoie F, Pujol JL, Quantin X, Quéré I, Ramdani S, Ribstein J, Rédini-Martinez I, Richard S, Ritchie K, Riso JP, Rivier F, Robine JM, Rolland C, Royère E, Sablot D, Savy JL, Schifano L, Senesse P, Sicard R, Stephan Y, Strubel D, Tallon G, Tanfin M, Tassery H, Tavares I, Torre K, Tribout V, Uziel A, Van de Perre P, Venail F, Vergne-Richard C, Vergotte G, Vian L, Vialla F, Viart F, Villain M, Viollet E, Ychou M, Mercier J. (2016).“MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy Ageing.J Frailty Aging. 2016;5(4):233-241.

Bousquet J, Barbara C, Bateman E, Bel E, Bewick M, Chavannes NH, Cruz AA, Haahtela T, Hellings PW, Khaltaev N, Lodrup Carlsen K, Muraro A, Cordeiro CR, Rosado-Pinto J, Samolinski B, Strandberg T, Valiulis A, Yorgancioglu A, Zuberbier T; AIRWAYS-ICPs working group.(comprenant de nombreux membres de l’Unité : Bourdin A, Hayot M, Mercier J). (2016) “AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation.Eur Respir J. 2016 Apr;47(4):1028-33. (IF=10,57).

Carillon J, Jover B, Cristol JP, Rouanet JM, Richard S and Virsolvy A. (2016). “Dietary supplementation with a specific melon concentrate reverses vascular dysfunction induced by cafeteria diet.Food & Nutrition Research 2016, 60: 32729 (IF 2,04)

Champeroux P, Le Guennec JY, Jude S, Laigot C, Maurin A, Sola ML, Fowler JS, Richard S, Thireau J. ( 2016). “The high frequency relationship: implications for torsadogenic hERG blockers. “  Br J Pharmacol. 173(3):601-12. (IF=5,49).

Charriot J, Vachier I, Halimi L, Gamez AS, Boissin C, Salama M, Cucu-Jarjour A, Ahmed E, Bourdin A. (2016). “Future treatment for asthma.Eur Respir Rev. 2016 Mar;25(139):77-92.

Colson PH, Gaudard P, Fellahi JL, Bertet H, Faucanie M, Amour J, Blanloeil Y, Lanquetot H, Ouattara A, Picot MC; ARCOTHOVA group. (2016). “Active Bleeding after Cardiac Surgery: A Prospective Observational Multicenter Study. . “ PLoS One. 2016 Sep 2;11(9):e0162396. (IF=2,81).

Colson PH, Virsolvy A, Gaudard P, Charrabi A, Corbani M, Manière MJ, Richard S, Guillon G. (2016). “Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile.Pharmacol Res. 2016 Nov;113(Pt A):257-264. (IF=4,48).

Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Thiberville L, Leroy S, Marceau A, Laroumagne S, Mallet JP, Dukic S, Barbe C, Bulsei J, Jolly D, Durand-Zaleski I, Marquette CH; REVOLENS Study Group.(2016). “Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial. “ JAMA. 315(2):175-184. (IF=44,40).

Jaffuel D, Mallet JP, Combes N, Palot A, Rabec C, Molinari N, Jaber S, Bourdin A. (2016). “[Adaptive servo-ventilation after the SERVE-HF study: The swan song?]Rev Mal Respir. 2016 May 4. 2016 Sep;33(7):641-4. (IF=0,58).

Khoueiry Z, Albenque JP, Providencia R, Combes S, Combes N, Jourda F, Sousa PA, Cardin C, Pasquie JL, Cung TT, Massin F, Marijon E, Boveda S. (2016). “Outcomes after cryoablation vs. radiofrequency in patients with paroxysmal atrial fibrillation: impact of pulmonary veins anatomy.Europace. 2016 Sep;18(9):1343-51. (IF=4,53).

Lee YY, Galano JM, Oger C, Vigor C, Guillaume R, Roy J, Le Guennec JY, Durand T, Lee JC. (2016). “Assessment of Isoprostanes in Human Plasma: Technical Considerations and the Use of Mass Spectrometry. “  Lipids. 2016 Nov;51(11):1217-1229. (IF=1,93). 

Le Guennec JY*, Thireau J*, Roussel J, Roy J, Richard S, Richard S, Martel E, Champéroux P. (2016). “Inter-individual variability and modeling of electrical activity: a possible new approach to explore cardiac safety? “  Sci Rep. 2016 Nov 30;6:37948. (IF=4,26).

Magnan A, Bourdin A, Prazma CM, Albers FC, Price RG, Yancey S, Ortega H. (2016). “ Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment. “ Allergy. 2016 Sep;71(9):1335-44 (IF=7,36).

Molinari N, Chanez P, Roche N, Ahmed E, Vachier I, Bourdin A. (2016). “Rising total costs and mortality rates associated with admissions due to COPD exacerbations. “  Respir Res. 2016 Nov 14;17(1):149. (IF=3,84).

Raherison C, Bourdin A, Bonniaud P, Deslée G, Garcia G, Leroyer C, Taillé C, De Blic J, Dubus JC, Tillié-Leblond I, Chanez P. (2016). “Updated guidelines (2015) for management and monitoring of adult and adolescent asthmatic patients (from 12 years and older) of the Société de pneumologie de langue française (SPLF) (summary).Rev Mal Respir. 2016 Apr;33(4):271-8. (IF=0,62). . (IF=0,58).

Raherison C, Bourdin A, Bonniaud P, Deslée G, Garcia G, Leroyer C, Taillé C, De Blic J, Dubus JC, Tillié-Leblond I, Chanez P. (2016). “  Updated guidelines (2015) for management and monitoring of adult and adolescent asthmatic patients (from 12 years and older) of the Société de Pneumologie de Langue Française (SPLF) (Full length text). “   Rev Mal Respir. 2016 Apr;33(4):279-325 (IF=0,58).

Rieusset J, Fauconnier J, Paillard M, Belaidi É,Tubbs É, Chauvin M-A, Durand A, Bravard A, Teixeira G, Bartosch B, Michelet M, Theurey P, Vial G, Demion M, Blond É, Zoulim F, Gomez L, Vidal H, Lacampagne A and Michel Ovize M. (2016). “Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance. “ Diabetologia. 59(3):614-23. (IF=6,08).

Roussel J, Labarthe F, Thireau J, Ferro F, Farah C, Roy J, Horiuchi M, Tardieu M, Lefort B, Benoist JF, Lacampagne A, Richard S, Fauconnier J, Babuty D, Le Guennec JY. (2016). “Carnitine Deficiency Induces A Short Qt Syndrome.Heart Rhythm. 13(1):165-74. (IF=4,87).

Roussel J, Champeroux P, Roy J, Richard S, Fauconnier J, Le Guennec JY, Thireau J. (2016). The Complex QT/RR Relationship in Mice. “  Sci Rep. 2016 May 3;6:25388. (IF= 4,26).

Roussel J, Thireau J, Farah C, Le Guennec JY, Babuty D. (2016). “Author’s reply to carnitine and ventricular repolarization: A complex link? Heart Rhythm. 2016 Aug;13(8):1760. (IF= 4,87).

Roy J, Le Guennec JY, Galano JM, Thireau J, Bultel-Poncé V, Demion M, Oger C, Lee JC, Durand T. (2016). “Non-enzymatic cyclic oxygenated metabolites of omega-3 polyunsaturated fatty acid: Bioactive drugs? “ Biochimie, 120:56-61. (IF= 3,11).

Roy J, Fauconnier J, Oger C, Farah C, Angebault-Prouteau C, Thireau J, Bideaux P, Scheuermann V, Bultel-Poncé V, Demion M, Galano JM, Durand T, Lee JC, Le Guennec JY. (2016). “Non-enzymatic oxidized metabolite of DHA, 4(RS)-4-F4t-neuroprostane protects the heart against reperfusion injury.Free Radic Biol Med. 2016 Dec 5;102:229-239. (IF=5,61).

Sitbon O, Sattler C, Bertoletti L, Savale L, Cottin V, Jaïs X, De Groote P, Chaouat A, Chabannes C, Bergot E, Bouvaist H, Dauphin C, Bourdin A, Bauer F, Montani D, Humbert M, Simonneau G. (2016). “Initial dual oral combination therapy in pulmonary arterial hypertension.Eur Respir J. 2016 Jun;47(6):1727-36. (IF= 10,57).

Taillé C, Bourdin A, Garcia G. (2016). “Biomarkers in asthma]. “  Presse Med. 016 Nov;45(11):1019-1029. (IF=1,07).

Torrente AG, Mesirca P, Neco P, Rizzetto R, Dubel S, Barrere C, Sinegger-Brauns M, Striessnig J, Richard S, Nargeot J, Gomez AM, Mangoni ME. (2016). “L-type Cav1.3 Channels Regulate Ryanodine Receptor-dependent Ca2+ Release during Sino-Atrial Node Pacemaker Activity. “ Cardiovasc Res. 2016, 109(3):451-61. (IF=5,88).


Année 2015

Ader I, Gstalder C, Bouquerel P, Golzio M, Andrieu G, Zalvidea S, Richard S, Sabbadini RA, Malavaud B, Cuvillier O. (2015). “Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer.Oncotarget. 6(15):13803-13821. (IF= 5,01).

Alagha K, Jarjour B, Bommart S, Aviles B, Varrin M, Gamez AS, Molinari N, Vachier I, Paganin F, Chanez P, Bourdin A. (2015). ”Persistent severe hypereosinophilic asthma is not associated with airway remodeling.Respir Med. 109(2):180-7. (IF=3,04).

Alagha K, Bourdin A, Chanez P. (2015). ”Reply: Increased Mortality during Bleomycin-induced Pulmonary Fibrosis due to Low Endogenous Activated Protein C Levels. ” Am J Respir Crit Care Med. ;192(10):1259-60. (IF=13,12).

Berthet JP, Caro AG, Solovei L, Gilbert M, Bommart S, Gaudard P, Canaud  L, Alric P, Marty-Ané CH. (2015). “Titanium Implant Failure After Chest Wall Osteosynthesis.The Annals of Thoracic Surgery, 99(6):1945-52 (IF=3,02).

Bommart S, Marin G, Bourdin A, Revel MP, Klein F, Hayot M, Vachier I, Chanez P, Picot MC, Mercier J, Molinari N, Vernhet-Kovacsik H. (2014) “Computed tomography quantification of airway remodelling in normal ageing subjects: a cross sectional study. “ Eur Respir J. 45(4):1167-70. (IF=7,12).

Boulate D, Perros F, Dorfmuller P, Arthur J, Guihaire J, Lamrani L, Decante B, Humbert M, Eddahibi S, Dartevelle P, Fadel E, Mercier O. (2015). “Pulmonary microvascular lesions regress in reperfused chronic thromboembolic pulmonary hypertension. “. The Journal of Heart and Lung Transplantation, 34(3):457-467 (IF= 7,51).

Canaud L, Marty-Ané C, Alric P. (2015).”Regarding « Comparison of treatment strategies for thoracic endograft infection »J Vasc Surg. 61(2):587. (IF= 3,49).

Champeroux P, Thireau J, Judé S, Laigot-Barbé C, Maurin A, Sola M, Fowler J, Richard S, Le  Guennec JL. (2015). “Dofetilide induced QT interval short term variability and ventricular arrhythmias are dependent on high frequency autonomic oscillations.Br J Pharmacol. 172(11):2878-2891 (IF=5,26).

Faure EM, Canaud L, Cathala P, Serres I, Marty-Ané C, Alric P. (2015).”Assessment of abdominal branch vessel patency after bare-metal stenting of the thoracoabdominal aorta in a human ex vivo model of acute type B aortic dissection.J Vasc Surg. 61(5):1299-305. (IF=3,49).

Finan A et Richard S. (2015). ”Stimulating endogenous cardiac repair.”  Front Cell Dev Biol. 2015 Sep 29;3:57.

Galano JM, Lee JCY, Gladine C, Comte B, Le Guennec JY, Oger C and Durand T. (2014).  “Non-enzymatic cyclic oxygenated metabolites of adrenic, docosahexaenoic, eicosapentaenoic and α-linolenic acids; bioactivities and potential use as biomarkers. (BBA) Molecular and Cell Biology of Lipids . 1851(4):446-455 (IF= 4.78).

Gaudard P, Mourad M, Eliet J, Zeroual N, Culas G, Rouvière P, Albat B, Colson P. (2015). “Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.Crit Care. 19(1):363. (IF=4,95).

Gamez AS, Gras D, Petit A, Knabe L, Molinari N, Vachier I, Chanez P, Bourdin A.(2015).”Supplementing defect in Club Cell Secretory Protein attenuates airway inflammation in COPD.  Chest. 147(6):1467-76. (IF=7.14).

Granier M, Winum PF, Granier M, Liaud P, Cayla G, Messner P, Pasquie JL, Schuster I. (2015). ”Real-time atrial wall imaging during radiofrequency ablation in a porcine model.Heart Rhythm. 12(8):1827-35. (IF=4,39).

Groupe d’étude MACVIA-LR. avec  224 Collaborateurs.   (2015). ” Le site de référence du Partenariat européen d’innovation pour un vieillissement actif et en bonne santé MACVIA-LR (contre les maladies chroniques pour un vieillissement en bonne santé en Languedoc-Roussillon).Presse Med. 44 Suppl 1:S6-S22 (IF=1,01).

Groupe d’étude MACVIA-LR  avec 224 Collaborateurs.  (2015).” Introduction. .”  Presse Med. 44 Suppl 1:S1-5. (IF=1,01).

Hédon C, Khoueiry Z, Verges M, Pasquié JL. (2015). “Late intracardiac orthopedic wire migration presenting as tamponade and stroke. “.   Eur Heart J. 36(24):1546 (IF=15,06).

Izikki M, Hoang, E, Draskovic I, Mercier O, Lecerf F, Lamrani L, Liu, WY, Guignabert C, Fadel E, Dorfmuller P, Humbert M, Londoño-Vallejo A and Eddahibi S. (2015).“ Telomere Maintenance Is a Critical Determinant in the Physiopathology of Pulmonary Hypertension..“J Am Coll Cardiol. 66(17):1942-1943. (IF=17,76).

Jacquin S, Rincheval V, Mignotte B, Richard S, Humbert M, Mercier O, Londoño-Vallejo A, Fadel E, Eddahibi S. (2015); “Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats.PLoS One. 10(6):e0131940. (IF=3,06).  

Klug D, Commeau P, Defaye P, Thambo JB, Gras D, Aubry P, Pasquie JL, Guerin P, Teiger E, Koning R, Piot O; Heart Rhythm, Pacing Group, the Atheroma, Interventional Cardiology Group of the French Society of Cardiology. (2015). “Percutaneous occlusion of the left atrial appendage: An expert consensus statement.Arch Cardiovasc Dis. 108(8-9):460-7.(IF=2,27).

Knabe L, Fort A, Chanez P, Bourdin A. (2015). « Club cells and CC16: another « smoking gun »? (With potential bullets against COPD).”  Eur Respir J. 45(6):1519-20. (IF= 8,33).

Mahida S, Derval N, Sacher F, Leenhardt A, Deisenhofer I, Babuty D, Schläpfer J, de Roy L, Frank R, Yli-Mayry S, Mabo P, Rostock T, Nogami A, Pasquié JL, de Chillou C, Kautzner J, Jesel L, Maury P, Berte B, Yamashita S, Roten L, Lim HS, Denis A, Bordachar P, Ritter P, Probst V, Hocini M, Jaïs P, Haïssaguerre M. (2015). “Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome.J Am Coll Cardiol. 65(2):151-9. (IF= 17,76).

Meschin P, Demion M, Cazorla O, Finan A, Thireau J, Richard S, Lacampagne A. (2015). “p11 modulates calcium handling through 5-HT4R pathway in rat ventricular cardiomyocytes. “ Cell Calcium. 58(6):549-57. (IF=2,91).

Miquerol L, Thireau J, Bideaux P, Sturny R, Richard S, Kelly RG. (2015).”Endothelial Plasticity Drives Arterial Remodeling Within the Endocardium Following Myocardial Infarction.Circ Res. 116(11):1765-71 (IF=11,55).

Meyer G, Andre L, Kleindienst A, Singh F, Tanguy S, Richard S, Obert P, Boucher F, Jover BF, Cazorla O, Reboul C. (2015). “Carbon monoxide increases inducible NOS expression which mediates CO-induced myocardial damage during ischemia-reperfusion. “ Am J Physiol Heart Circ Physiol. 308(7):H759-H767. (IF=3,32).

Molinari N , Briand C,  Vachier I, Malafaye ,  Aubas P, Georgescu V, Roche N,  Chanez P &  Bourdin A. (2015).  “Hospitalizations for COPD Exacerbations: Trends and Determinants of Death.COPD: Journal of Chronic Obstructive Pulmonary Disease. 12(6):621-7. (IF=2,16).

Molinari N, Abou-Badra M, Marin G, Ky CL, Amador N, Gamez AS, Vachier I, Bourdin A. (2015). “Is generalization of exhaled CO assessment in primary care helpful for early diagnosis of COPD? “ BMC Pulm Med.;15(1):44. (IF=2,33).

Pahus L, Alagha K, Sofalvi T, Vachier I, Bourdin A, Molinari N, Chanez P; COBRA consortium. (2015). “External Validity of Randomized Controlled Trials in Severe Asthma”. Am J Respir Crit Care Med. 192(2):259-61. (IF= 13,12).

Paulis L, Fauconnier J, Cazorla O, Thireau J, Soleti R, Vidal B, Ouillé A, Bartholome M, Bideaux P, Roubille F, Le Guennec JY, Andriantsitohaina R, Martínez MC, Lacampagne A. (2015).”Activation of Sonic hedgehog signaling in ventricular cardiomyocytes exerts cardioprotection against ischemia reperfusion injuries.Sci Rep. ;5:7983. (IF=5.23).

Perros F, Ranchoux B, Izikki M, Bentebbal S, Happé C, Antigny F, Jourdon P, Dorfmüller P, Lecerf F, Fadel E, Simonneau G, Humbert M, Bogaard HJ, Eddahibi S. ” Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.J Am Coll Cardiol. 2015 Feb 24;65(7):668-80. (IF=17,76)

Priou P, d’Ortho MP, Damy T, Davy JM, Gagnadoux F, Gentina T, Meurice JC, Pepin JL, Tamisier R, Philippe C. (2015). «Adaptive servo-ventilation: How does it fit into the treatment of central sleep apnoea syndrome? Expert opinions. Rev Mal Respir. 32(10):1072-81. IF= 0,54).

Roger S, Gillet L, Le Guennec JY, Besson P. (2015). Voltage-gated sodium channels and cancer: is excitability their primary role? Front Pharmacol.; 6:152. (IF=4,42).

Romano-Bertrand S, Beretta M, Jean-Pierre H, Frapier JM, Calvet B, Parer S, Jumas-Bilak E. (2014). ”Propionibacterium acnes populations involved in deep pathological samples and their dynamics along the cardiac surgical pathway.Eur J Clin Microbiol Infect Dis. 34(2):287-301 (IF=2.86).

Romano-Bertrand S, Frapier JM, Calvet B, Colson P, Albat B, Parer S, Jumas-Bilak E. (2015) “Dynamics of the surgical microbiota along the cardiothoracic surgery pathway.“  Front Microbiol. 5:787. (IF=4,16).

Roussel J, Thireau J, Brenner C, Saint N, Scheuermann V, Lacampagne A, Le Guennec JY, Fauconnier J. (2015). ”Palmitoyl-carnitine increases RyR2 oxidation and sarcoplasmic reticulum Ca2+ leak in cardiomyocytes: role of adenine nucleotide translocase.Biochim Biophys Acta. Molec basis of Diseases1852(5):749-758 (IF= 5.16).

Roy J, Oger C, Thireau J, Roussel J, Mercier-Touzet O, Faure D, Pinot E, Farah C, Taber DF, Cristol JP,  JCY, Lacampagne A, Galano JM, Durand T,  Le Guennec JY. (2015). “Non-enzymatic lipid mediators, neuroprostanes, exert the anti-arrhythmic properties of docosahexaenoic acid. “ . Free Radical Biology and Medicine. 86:269-278. (IF=5,78).

Roy J, Oliveira LT, Oger C, Galano JM, Bultel-Poncé V, Richard S, Guimaraes AG, Vilela JM, Andrade MS, Durand T, Besson P, Mosqueira VC, Le Guennec JY. (2015). «Polymeric nanocapsules prevent oxidation of core-loaded molecules: evidence based on the effects of docosahexaenoic acid and neuroprostane on breast cancer cells proliferation.J Exp Clin Cancer Res. 34(1):155. (IF=4,36).

Solecki K, Dupuy AM, Kuster N, Leclercq F, Gervasoni R, Macia JC, Cung TT, Lattuca B, Cransac F, Cade S, Pasquié JL, Cristol JP, Roubille F. (2015). “Kinetics of high-sensitivity cardiac troponin T or troponin I compared to creatine kinase in patients with revascularized acute myocardial infarction. “ Clin Chem Lab Med. 53(5):707-14. (IF=3,02).

Teixeira G, Chiari P, Fauconnier J, Abrial M, Couture-Lepetit E, Harisseh R, Pillot B, Lacampagne A, Tourneur Y, Gharib A, Ovize M. (2015).”Involvement of Cyclophilin D and Calcium in Isoflurane-induced Preconditioning.Anesthesiology.123(6):1374-84.. (IF=5,55).

Thireau J, Zalvidea S, Meschin P, Pasquié JL, Aimond F, Richard S. (2015). “ACE inhibitor delapril prevents Ca2+-dependent blunting of IK1 and ventricular arrhythmia in ischemic heart disease.Curr Mol Med. ;15(7):642-51. (IF=2,91).

Vidé J, Virsolvy A, Romain C, Ramos J, Jouy N, Richard S, Cristol JP, Gaillet S, Rouanet JM. (2015). “Dietary silicon-enriched spirulina improves early atherosclerosis markers in hamsters on a high-fat diet.Nutrition.;31(9):1148-54.(IF=2,84).

Virsolvy A, Farah C, Pertuit N, Kong L, Lacampagne A, Reboul C, Aimond F, Richard S. (2015). “Antagonism of Nav channels and α1-adrenergic receptors contributes to vascular smooth muscle effects of ranolazine. ”. Scientific  Reports ;5:17969 (IF=5,23).

Année 2014


Alagha K, Palot A, Sofalvi T, Pahus L, Gouitaa M, Tummino C, Martinez S, Charpin D, Bourdin A, Chanez P. (2014).”Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases. ” Ther Adv Chronic Dis. 5(2):85-98. Review.

– Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, Ortega HG, Pavord ID; SIRIUS Investigators. .(parmi les collaborateurs A. Bourdin). (2014). ”Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. ”  N Engl J Med.;371(13):1189-97. (IF=55,87).

-Bergot E, Sitbon O, Cottin V, Prévot G, Canuet M, Bourdin A, de Groote P, Rottat L, Gressin V, Jaïs X, Humbert M, Simonneau G. (2014). ”Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: Data from the French pulmonary hypertension registry.Int J Cardiol. 72(3):561-7. (IF=4,04).

 Bommart, S., Bourdin, A., Marin, G., Berthet, J-P., Pujol, J-L., Serre, I., Molinari, N., Marty-Ané, C., Kovacsik, H. (2014). “Impact of Preoperative Marking Coils on Surgical and Pathologic Management of Impalpable Lung Nodules.Ann Thorac Surg.  97(2):414-8. (IF=3.85).

– Bommart S, Marin G, Bourdin A, Molinari N, Klein F, Hayot M, Vachier I, Chanez P, Mercier J, Vernhet-Kovacsik H. (2014). “Relationship between CT air trapping criteria and lung function in small airway impairment quantification.“ – BMC Pulmonary Medicine, 14(1):29. (IF= 2.40).

Bourdin A, Molinari N, Vachier I, Vanin M, Marin G, Gamez AS, Paganin F and Chanez P, (2014).  “Prognostic value of cluster analysis of severe asthma phenotypes. “  Journal of Allergy and Clinical Immunology 134(5):1043-50. (IF= 11,48).

– Bousquet J, Bourdin A, Demoly P. (2014).  “Do we need new asthma control tests?  “ Eur Respir J.  44(5):1116-8. (IF=7.64).

– Bousquet J, Bourdin A, Demoly P. (2014). “Safety of β2-agonists: a 50-year debate closed?Eur Respir J. , 43(1):6-9. ( IF=7.64).

Bousquet J, Jorgensen C, Dauzat M, Cesario A, Camuzat T, Bourret R, Best N, Anto JM, Abecassis F, Aubas P, Avignon A, Badin M, Blain H, Bourdin A, Bringer J, Camu W, Cayla G, Costa DJ, Courtet P, Cristol JP, Demoly P, de la Coussaye JE, Fesler P, Gouzi F, Gris JC, Guillot B, Hayot M, Jeandel C, Jonquet O, Journot L, Mathieu G, Morel J, Ninot G, Pelissier JY, Picot MC, Rabier-Pontal F, Robine JM, Rodier M, Sultan A, Wojtusciszyn A, Auffray C, Balling R, Barbara C, Cambon-Thomsen A, Chavannes NH, Chuchalin A, Crooks G, Dedeu A, Fabbri LM, Garcia-Aymeric J, Hassan J, Gomes EM, Palkonen S, Piette F, Pison C, Price D, Samolinski B, Schunemann HJ, Sterk PJ, Yiallouros P, Roca J, Perre PV, Mercier J. (2014). “System Medicine Approaches for the Definition of Complex Phenotypes in Chronic Diseases and Ageing. From Concept to Implementation and Policies. “ Curr Pharm Des. 20(38):5928-44. (IF=3.45).

– Brunkwall J, Kasprzak P, Verhoeven E, Heijmen R, Taylor P; ADSORB Trialists; ADSORB Trialists. (((avvvec parmi les collaborateus Alric P); (2014). “Endovascular Repair of Acute Uncomplicated Aortic Type B Dissection Promotes Aortic Remodelling: 1 Year Results of the ADSORB Trial. Eur J Vasc Endovasc Surg. 48(3):285-91.(IF= 2,49).

Canaud L, Faure EM, Branchereau P, Ozdemir BA Marty-Ané C, Alric P.(2014). Experimental Evaluation of Complete Endovascular Arch Reconstruction by In Situ Retrograde Fenestration. Annals of Thoracic Surg. 98(6):2086–2090 (IF= 3.85).

– Canaud L, D’Annoville T, Ozdemir BA, Marty-Ané C, Alric P. (2014). “Combined endovascular and surgical approach for aortobronchial fistula. J Thorac Cardiovasc Surg. 148(5):2108-11. (IF=4,12).

–  Canaud L, Faure EM,  Ozdemir BA,  Alric P, Thompson M. (2014).” Systematic review of outcomes of combined proximal stentgrafting with distal bare stenting for management of aortic dissection ” Annals of Cardiothoracic.Surgery 3(3):223-233.

– Carillon J, Knabe L, Montalban A, Stévant M, Keophiphath M, Lacan D, Cristol JP, Rouanet JM. (2014). “Curative diet supplementation with a melon superoxide dismutase reduces adipose tissue in obese hamsters by improving insulin sensitivity.Mol Nutr Food Res. 58(4):842-50. .  (IF=4,60).

– Combes N, Jaffuel D, Cayla G, Granier M, Borel JC, Corne P, Jonquet O, Jaber S , Davy JM, Pépin JL. (2014) “Pressure-dependent hemodynamic effect of continuous positive airway pressure in severe chronic heart failure: A case series.Int J Cardiol. 171(3):e104-5. (IF=5,22).

– Dague E, Genet G, Lachaize V, Guilbeau-Frugier C, Fauconnier J, Mias C, Payré B, Chopinet L, Alsteens D, Kasas S, Severac C, Thireau J, Heymes C, Honton B, Lacampagne A, Pathak A, Sénard JM, Galés C . (2014).”Atomic force and electron microscopic-based study of sarcolemmal surface of living cardiomyocytes unveils unexpected mitochondrial shift in heart failure.J Mol Cell Cardiol. 74:162-72. (IF=4,65).

Demion M, Thireau J, Gueffier M, Finan A, Khoueiry Z, Cassan C, Serafini N, Aimond F, Granier M, Pasquié JL, Launay P, Richard S. (2014). “Trpm4 gene invalidation leads to cardiac hypertrophy and electrophysiological alterations. “  PLoS One. 22;9(12):e115256. (IF= 3.23).

– Driffort V, Gillet L, Bon E, Marionneau-Lambot S, Oullier T, Joulin V, Collin C, Pagès JC, Jourdan ML, Chevalier S, Bougnoux P, Le Guennec JY, Besson P, Roger S. (2014). Ranolazine inhibits NaV1.5-mediated breast cancer cell invasiveness and lung colonization. Mol Cancer. 13(1):264.  (IF=4,26).

-Faure, E.M., Canaud, L., Agostini, C., Shaub, R., Böge, G., Marty-Ané, C., Alric, P. (2014). “Reintervention after thoracic endovascular aortic repair of complicated aortic dissection.”. J Vasc Surg.  59(2):327-33. (IF=3,02).

– Faure, E.M., Canaud, L., Cathala, P., Serres, I.,  Marty-Ané, C., Alric, P. (2014). “Human ex-vivo model of Stanford type B aortic dissection.”  Journal of Vascular Surgery: 60(3):767-75. (IF= 3,02).

– Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R; SIGNIFY Investigators. (2014). “Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure. ADD POLISH INVESTIGATORS. “ (Avec comme collaborateur: Davy JM) N Engl J Med. 371(12):1091-9. 31. (IF=55,87).

– Gore B, Izikki M, Mercier O, Dewachter L, Fadel E, Humbert M, Dartevelle P, Simonneau G, Naeije R, Lebrin F, Eddahibi S. (2014). ” Key Role of the Endothelial TGF-β/ALK1 / Endoglin Signaling Pathway in Humans and Rodents Pulmonary Hypertension. PLoS One.;9(6):e100310. (IF= 3.23).

– Guihaire, J., Haddad, F., Boulate, D., Capderou, A., Decante, B., Flécher, E.,  Eddahibi, S., Dorfmüller, P., Hervé, P.,Humbert, M., Verhoye, J.P., Dartevelle, P., Mercier, O., Fadel, E. (2014). “Right Ventricular Plasticity In A Porcine Model of Chronic Pressure Overload The Journal of Heart and Lung Transplantation  33(2):194-202. (IF=6,65).

– Hiemstra PS, Bourdin A. (2014).”Club cells, CC10 and self-control at the epithelial surface. ”Eur Respir J. 44(4):831-2. (IF=7.64).

– Khalifé-Hocquemiller T, Sage E, Dorfmuller P, Mussot S, Le Houérou D, Eddahibi S, Fadel E.(2014). “Exogenous Surfactant Attenuates Lung Injury From Gastric-Acid Aspiration During Ex Vivo Reconditioning in Pigs.Transplantation, 97(4):413-8., (IF=3.83).

– Kolb C, Sturmer M, Sick P, Reif S, Davy JM, Molon G, Schwab JO, Mantovani G, Dan D, Lennerz C, Borri-Brunetto A, Babuty D. (2014). “Reduced Risk for Inappropriate Implantable Cardioverter-Defibrillator Shocks With Dual-Chamber Therapy Compared With Single-Chamber Therapy: Results of the Randomized OPTION Study (Optimal Anti-Tachycardia Therapy in Implantable Cardioverter-Defibrillator Patients Without Pacing Indications).  “. JACC Heart Fail. 2(6):611-9. (IF= Soon).

– Lenoir O, Milon M, Virsolvy A, Hénique C, Schmitt A, Massé JM, Kotelevtsev Y, Yanagisawa M, Webb DJ, Richard S  and Tharaux PL. (2014).  “Direct Action of Endothelin-1 on Podocytes Promotes Diabetic GlomerulosclerosisJASN. 25(5):1050-62.  (IF=9,34).

– Marin G, Molinari N, Gamez AS, Vachier I, Bourdin A. (2014). “Nonlinear weight and chronic obstructive pulmonary disease effect modeling to improve data fitting.Am J Respir Crit Care Med. 189(7):870-1. (IF= 13).

– Maury P, Audoubert M, Cintas P, Rollin A, Duparc A, Mondoly P, Chiriac AM, Acket B, Zhao X, Pasquié JL, Cardin C, Delay M, Sadron M, Carrié D, Galinier M, Davy JM, Arne-Bès MC, Raczka F. (2014). “Prevalence of Type 1 Brugada-ECG Pattern Following Administration of Class 1C Drugs in Patients with Type 1 Myotonic Dystrophy. Myotonic Dystrophy as a Part of the Brugada Syndrome.Heart Rhythm.  11(10):1721-7 (IF=5.08).

– Maury P, Lin C, Pasquié JL, Raczka F, Beck L, Taieb J, Mailhes C, Tourneret JY, Rollin A, Duparc A, Mondoly P, Winum P, Rolland P, Castanié F, Hallier B. (2014). “Detection of T-Wave Beat-By-Beat Variations prior to Ventricular Arrhythmias Onset in ICD-Stored Intracardiac Electrograms: The Endocardial T-Wave Alternans Study (ETWAS).Pacing Clin Electrophysiol. 37(11):1510-9 (IF=1,13).

-McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees.  (2014). “Angiotensin-neprilysin inhibition versus enalapril in heart failure. “(Avec comme collaborateur: Davy JM) N Engl J Med. 371(11):993-1004. (IF=55,87).

– Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P; MENSA Investigators.(parmi les collaborateurs A. Bourdin). (2014). ” Mepolizumab treatment in patients with severe eosinophilic asthma.N Engl J Med.;371(13):1198-207. (IF=55,87).

– Ortega H, Chupp G, Bardin P, Bourdin A, Garcia G, Hartley B, Yancey S, Humbert M. (2014). “The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophilia.Eur Respir J.  44(1):239-4.  (IF=7.64).

– Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR; INPULSIS Trial Investigators (avec parmi les collaborateurs A. Bourdin). (2014). “Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.N Engl J Med. 370(22):2071-82. (IF=55,87).

– Robinson JG, Nedergaard BS, Rogers WJ, Fialkow J, Neutel JM, Ramstad D, Somaratne R, Legg JC, Nelson P, Scott R, Wasserman SM, Weiss R; LAPLACE-2 Investigators, (parmi ces collaborateurs Davy JM). (2014).”Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.JAMA. 311(18):1870-82. (IF= 35,29).

Saketkoo LA, Mittoo S, Huscher D, Khanna D, Dellaripa PF, Distler O, Flaherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Bielecka OM, Lesage D, Merkel PA, Phillips K, Pittrow D, Swigris J, Antoniou K, Baughman RP, Castelino FV, Christmann RB, Christopher-Stine L, Collard HR, Cottin V, Danoff S, Highland KB, Hummers L, Shah AA, Kim DS, Lynch DA, Miller FW, Proudman SM, Richeldi L, Ryu JH, Sandorfi N, Sarver C, Wells AU, Strand V, Matteson EL, Brown KK, Seibold JR. (avec parmi les collaboratuers A. Bourdin).  (2014). “Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.Thorax.  69(5):436-444 (IF= 8.29).

– Servy A, Valeyrie-Allanore L, Alla F, Lechiche C, Nazeyrollas P, Chidiac C, Hoen B, Chosidow O, Duval X; Association Pour l’Etude et la Prévention de l’Endocardite Infectieuse Study Group.(collaboration avec Chanques G, Jung B, Frapier JM). (2014).  “Prognostic value of skin manifestations of infective endocarditis.JAMA Dermatol. 150(5):494-500. .  (IF=4,43).

Thireau J, Karam S, Roberge S, Roussel J, Aimond F, Cassan C, Gac A, Babuty D, Le Guennec JY, Lacampagne A, Fauconnier J, Richard S. (2014). “β-Adrenergic blockade combined with subcutaneous B-type natriuretic peptide: a promising approach to reduce ventricular arrhythmia in heart failure?Heart. 100(11):833-41. (IF=5,59).